Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.66
+0.11 (0.63%)
At close: Mar 6, 2026, 4:00 PM EST
17.80
+0.14 (0.79%)
After-hours: Mar 6, 2026, 7:58 PM EST
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $1.76 billion as of March 6, 2026. Its market cap has increased by 193.52% in one year.
Market Cap
1.76B
Enterprise Value
1.39B
1-Year Change
193.52%
Ranking
Category
Stock Price
$17.66
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $1.76B, an increase of 195.73%. That is a compound annual growth rate of 19.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.83B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.77B |
| Enliven Therapeutics | 1.76B |
| Sarepta Therapeutics | 1.75B |
| Galecto | 1.74B |